Pre-exposure Prophylaxis With Various Doses of Hydroxychloroquine Among Healthcare Personnel With High-Risk Exposure to COVID-19: A Randomized Controlled TrialPreventive Medicine Published on 2021-12-212022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome Antibody testing clinical benefit conducted confirmed COVID-19 case control group Controlled coronavirus coronavirus disease COVID 19 COVID-19 COVID-19 symptom dose Efficacy Enrollment evaluate exhibiting experimental group exposure to hcp HCQ healthcare personnel Hydroxychloroquine IgM/IgG Infection objective participant Participants patients Personal protective equipment Placebo placebo-controlled trial PPE pre-exposure prophylaxis Prevent Prophylaxis Randomized reported Result RT-PCR SARS-CoV-2 serology testing Side effect significantly study outcome subject tested the patient treated Trial [DOI] 10.7759/cureus.20572 PMC 바로가기 [Article Type] Preventive Medicine
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trialRandomized Controlled Trial Published on 2021-11-152022-10-04 Journal: Trials [Category] SARS, 임상, [키워드] adverse event Barcelona benefit conducted Control control group COVID-19 COVID-19 transmission diagnosed with COVID-19 double-blind Efficacy Efficacy and safety Epidemic evaluate evaluated Gastrointestinal symptom group Health-care workers healthcare worker high risk hospital Hydroxychloroquine incidence intervention arm low dose Mild nasopharyngeal National participant Placebo Placebo tablets placebo-controlled pre-exposure prophylaxis prevention Prophylaxis proportion randomized clinical trial reported Result Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR screened serious AE serology significantly higher Spain Study design study period supplementary material Treatment Trial [DOI] 10.1186/s13063-021-05758-9 PMC 바로가기 [Article Type] Randomized Controlled Trial
The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals오피오이드 의존 개인의 HIV 예방 서비스 이용에 대한 COVID-19의 영향Article Published on 2021-10-012022-09-11 Journal: Journal of community health [Category] SARS, 치료제, [키워드] access adverse effect adverse effects Appointment appointments Blood change changed COVID-19 COVID-19 pandemic difficulty disorder doctor drug enrolled equipment HIV HIV prevention HIV testing identify Impact individual Infection injection lab majority medication Methadone opioid Opioid use disorder participant People who inject drugs pre-exposure prophylaxis PrEP prevention Prophylaxis reduce reduced reported service sexually transmitted infection transmitted Treatment utilization with HIV [DOI] 10.1007/s10900-021-00979-0 PMC 바로가기 [Article Type] Article
Reduced sexual contacts with non-steady partners and less PrEP use among MSM in Belgium during the first weeks of the COVID-19 lockdown: results of an online surveyArticle Published on 2021-09-012023-07-12 Journal: Sexually transmitted infections [Category] SARS, [키워드] HIV pre-exposure prophylaxis preventive health services Sexual behaviour [DOI] 10.1136/sextrans-2020-054756 PMC 바로가기
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort StudyPreventive Medicine Published on 2021-08-262022-10-31 Journal: Cureus [Category] COVID-19, [키워드] 1:1 95% CI active against acute respiratory syndrome adhere applied assigned carried compassionate use Consensus control group coronavirus coronavirus disease COVID-19 COVID-19 prevention COVID-19 test died dose evaluate facilitate Follow-up healthcare personnel healthcare worker Hospitalization ICU Infection intensive care unit Ivermectin ivermectin group matching material offer outcome polymerase chain positive pre-exposure prophylaxis PrEP Previous studies Prophylaxis Randomized controlled trial required retrospective cohort reverse transcription risk reduction RT-PCR SARS-CoV-2 Science score secondary shown sick SPSS Statistical Package symptomatic SARS-CoV-2 infection [DOI] 10.7759/cureus.17455 PMC 바로가기 [Article Type] Preventive Medicine
The Impact of COVID-19 on Sexual Behavior and Psychosocial Functioning in a Clinical Sample of Men who have Sex with Men Using HIV Pre-exposure ProphylaxisOriginal Paper Published on 2021-06-102023-06-17 Journal: AIDS and Behavior [Category] MERS, SARS, [키워드] alcohol COVID-19 men who have sex with men (MSM) mood pre-exposure prophylaxis Sexual Behavior [DOI] 10.1007/s10461-021-03334-5 PMC 바로가기 [Article Type] Original Paper
Impact of the First Wave of the COVID-19 Pandemic on HIV/AIDS Programming in Kenya: Evidence from Kibera Informal Settlement and COVID-19 Hotspot CountiesArticle Published on 2021-06-032022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, [키워드] affected Analysis Antiretroviral therapy ART Care client conducted Contact COVID-19 COVID-19 pandemic determine electronic medical record Factors First wave food insecurity Food security Government Health healthcare facility HIV HIV/AIDS hotspot Impact indicated Kenya lack lockdown measures measure medication pandemic Pandemics participant Participants Personal protective equipment pre-exposure prophylaxis programming Prophylaxis prospective cohort study Randomly reduced reduction in Regulation reported Result retrospective selected significantly System Treatment Wave with HIV [DOI] 10.3390/ijerph18116009 PMC 바로가기 [Article Type] Article
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized TrialControlled Trial Published on 2021-06-012023-07-01 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, [키워드] COVID-19 Healthcare workers Hydroxychloroquine pre-exposure prophylaxis [DOI] 10.1093/cid/ciaa1571 PMC 바로가기 [Article Type] Controlled Trial
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study류마티스 질환 환자의 SARS-CoV-2 감염에 대한 하이드록시클로로퀸 사전 노출의 영향: 인구 기반 코호트 연구Article Published on 2021-04-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analysed Arthritis assessment attack rate Clinical data conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 in patient determine disease Effect HCQ HCQ therapy Health Insurance HIRA Hydroxychloroquine in vitro study infection with SARS-CoV-2 infections insurance investigated Korean logistic regression models lupus erythematosus MOST not differ Patient population-based cohort pre-exposure prophylaxis Prevent Prophylactic retrospective cohort study review rheumatic disease Rheumatic diseases rheumatoid arthritis SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 SLE student suggested systemic lupus erythematosus T-tests tested treated Treatment Usual dose [DOI] 10.1016/j.cmi.2020.12.003 PMC 바로가기 [Article Type] Article
Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine: results from a population-based prospective cohort in Catalonia, Spain, 2020클로로퀸 및 하이드록시클로로퀸에 노출된 환자의 COVID-19 발병률: 2020년 스페인 카탈로니아의 인구 기반 전향적 코호트 결과Research Published on 2021-03-042022-09-10 Journal: Eurosurveillance [Category] SARS, 치료제, [키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age analysed Chloroquine chloroquine/hydroxychloroquine Chronic exposure classification clinical trial Cohort cohort of patient Control controls coronavirus coronavirus disease COVID-19 COVID-19 case COVID-19 cases COVID-19 in patient COVID-19 incidence database drug exposure to female Follow-up hazard ratio Health health administration hospital hospitalisation Hydroxychloroquine hydroxychloroquine/chloroquine incidence rate Infection lower risk male not differ Patient pre-exposure prophylaxis primary care prospective cohort Protective respiratory Result risk risk of COVID-19 risk of infection SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe coronavirus disease Sex Spain two group two groups [DOI] 10.2807/1560-7917.ES.2021.26.9.2001202 PMC 바로가기 [Article Type] Research